Artificial Intelligence in Oncologic Imaging

Overview

Journal Eur J Radiol Open

Specialty Radiology

Date 2022 Oct 4

PMID 36193451

Authors

Melissa M Chen

Admir Terzic

Anton S Becker

Jason M Johnson

Carol C Wu

Max Wintermark

Christoph Wald

Jia Wu

Affiliations

Soon will be listed here.

Abstract

Radiology is integral to cancer care. Compared to molecular assays, imaging has its advantages. Imaging as a noninvasive tool can assess the entirety of tumor unbiased by sampling error and is routinely acquired at multiple time points in oncological practice. Imaging data can be digitally post-processed for quantitative assessment. The ever-increasing application of Artificial intelligence (AI) to clinical imaging is challenging radiology to become a discipline with competence in data science, which plays an important role in modern oncology. Beyond streamlining certain clinical tasks, the power of AI lies in its ability to reveal previously undetected or even imperceptible radiographic patterns that may be difficult to ascertain by the human sensory system. Here, we provide a narrative review of the emerging AI applications relevant to the oncological imaging spectrum and elaborate on emerging paradigms and opportunities. We envision that these technical advances will change radiology in the coming years, leading to the optimization of imaging acquisition and discovery of clinically relevant biomarkers for cancer diagnosis, staging, and treatment monitoring. Together, they pave the road for future clinical translation in precision oncology.

Citing Articles

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis.

Alum E Discov Oncol. 2025; 16(1):313.

PMID: 40082367 PMC: 11906928. DOI: 10.1007/s12672-025-02064-7.

Artificial intelligence in the radiological diagnosis of cancer.

Alkhalifah B Bioinformation. 2025; 20(9):1512-1515.

PMID: 39917228 PMC: 11795495. DOI: 10.6026/9732063002001512.

Enhanced MRI-based brain tumour classification with a novel Pix2pix generative adversarial network augmentation framework.

Precious Onakpojeruo E, Mustapha M, Ozsahin D, Ozsahin I Brain Commun. 2024; 6(6):fcae372.

PMID: 39494363 PMC: 11528519. DOI: 10.1093/braincomms/fcae372.

Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot.

Patell R, Zwicker J, Singh R, Mantha S Bleeding Thromb Vasc Biol. 2024; 3(Suppl 1).

PMID: 39323613 PMC: 11423546. DOI: 10.4081/btvb.2024.123.

Generative Adversarial Networks (GANs) in the Field of Head and Neck Surgery: Current Evidence and Prospects for the Future-A Systematic Review.

Michelutti L, Tel A, Zeppieri M, Ius T, Agosti E, Sembronio S J Clin Med. 2024; 13(12).

PMID: 38930087 PMC: 11204848. DOI: 10.3390/jcm13123556.

References

Ma M, Liu R, Wen C, Xu W, Xu Z, Wang S . Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms. Eur Radiol. 2021; 32(3):1652-1662. DOI: 10.1007/s00330-021-08271-4. View

Johnson P, Recht M, Knoll F . Improving the Speed of MRI with Artificial Intelligence. Semin Musculoskelet Radiol. 2020; 24(1):12-20. PMC: 7416509. DOI: 10.1055/s-0039-3400265. View

Ardila D, Kiraly A, Bharadwaj S, Choi B, Reicher J, Peng L . End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019; 25(6):954-961. DOI: 10.1038/s41591-019-0447-x. View

Dillman J, Davenport M . Gadolinium retention - 5 years later…. Pediatr Radiol. 2020; 50(2):166-167. DOI: 10.1007/s00247-019-04540-z. View

Larsen M, Aglen C, Lee C, Hoff S, Lund-Hanssen H, Lang K . Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program. Radiology. 2022; 303(3):502-511. PMC: 9131175. DOI: 10.1148/radiol.212381. View

Wu J, Mayer A, Li R . Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy. Semin Cancer Biol. 2020; 84:310-328. PMC: 8319834. DOI: 10.1016/j.semcancer.2020.12.005. View

Wiggins W, Magudia K, Schmidt T, OConnor S, Carr C, Kohli M . Imaging AI in Practice: A Demonstration of Future Workflow Using Integration Standards. Radiol Artif Intell. 2021; 3(6):e210152. PMC: 8637229. DOI: 10.1148/ryai.2021210152. View

Bae S, Choi Y, Ahn S, Chang J, Kang S, Kim E . Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction. Radiology. 2018; 289(3):797-806. DOI: 10.1148/radiol.2018180200. View

Brendlin A, Peisen F, Almansour H, Afat S, Eigentler T, Amaral T . A Machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma. J Immunother Cancer. 2021; 9(11). PMC: 8603266. DOI: 10.1136/jitc-2021-003261. View

10.

Huang P, Lin C, Li Y, Tammemagi M, Brock M, Atkar-Khattra S . Prediction of lung cancer risk at follow-up screening with low-dose CT: a training and validation study of a deep learning method. Lancet Digit Health. 2020; 1(7):e353-e362. PMC: 7450858. DOI: 10.1016/S2589-7500(19)30159-1. View

11.

Akcakaya M, Moeller S, Weingartner S, Ugurbil K . Scan-specific robust artificial-neural-networks for k-space interpolation (RAKI) reconstruction: Database-free deep learning for fast imaging. Magn Reson Med. 2018; 81(1):439-453. PMC: 6258345. DOI: 10.1002/mrm.27420. View

12.

Allen B, Agarwal S, Coombs L, Wald C, Dreyer K . 2020 ACR Data Science Institute Artificial Intelligence Survey. J Am Coll Radiol. 2021; 18(8):1153-1159. DOI: 10.1016/j.jacr.2021.04.002. View

13.

Trajanovski S, Mavroeidis D, Swisher C, Gebre B, Veeling B, Wiemker R . Towards radiologist-level cancer risk assessment in CT lung screening using deep learning. Comput Med Imaging Graph. 2021; 90:101883. DOI: 10.1016/j.compmedimag.2021.101883. View

14.

Makuku R, Khalili N, Razi S, Keshavarz-Fathi M, Rezaei N . Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy. J Immunol Res. 2021; 2021:6661406. PMC: 7925068. DOI: 10.1155/2021/6661406. View

15.

Wu J, Li C, Gensheimer M, Padda S, Kato F, Shirato H . Radiological tumor classification across imaging modality and histology. Nat Mach Intell. 2021; 3:787-798. PMC: 8612063. DOI: 10.1038/s42256-021-00377-0. View

16.

Haubold J, Hosch R, Umutlu L, Wetter A, Haubold P, Radbruch A . Contrast agent dose reduction in computed tomography with deep learning using a conditional generative adversarial network. Eur Radiol. 2021; 31(8):6087-6095. PMC: 8270814. DOI: 10.1007/s00330-021-07714-2. View

17.

Passiglia F, Cinquini M, Bertolaccini L, Del Re M, Facchinetti F, Ferrara R . Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. J Clin Oncol. 2021; 39(23):2574-2585. DOI: 10.1200/JCO.20.02574. View

18.

Provenzale J, Ison C, DeLong D . Bidimensional measurements in brain tumors: assessment of interobserver variability. AJR Am J Roentgenol. 2009; 193(6):W515-22. DOI: 10.2214/AJR.09.2615. View

19.

Zhang N, Liang R, Gensheimer M, Guo M, Zhu H, Yu J . Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer. Theranostics. 2020; 10(25):11707-11718. PMC: 7546006. DOI: 10.7150/thno.50565. View

20.

Rathore S, Chaddad A, Iftikhar M, Bilello M, Abdulkadir A . Combining MRI and Histologic Imaging Features for Predicting Overall Survival in Patients with Glioma. Radiol Imaging Cancer. 2021; 3(4):e200108. PMC: 8355783. DOI: 10.1148/rycan.2021200108. View